Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LEONARD H CALABRESE

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1467415265
CMS profile
65714
Location
CLEVELAND, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$210,188.31

147 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $54,104.53 48
GlaxoSmithKline, LLC. $44,917.21 21
GENZYME CORPORATION $39,606.35 12
E.R. Squibb & Sons, L.L.C. $16,406.78 14
Janssen Scientific Affairs, LLC $14,537.50 14
AbbVie Inc. $11,347.45 13
UCB, Inc. $8,095.31 9
Novartis Pharmaceuticals Corporation $7,662.60 4
Janssen Biotech, Inc. $5,893.75 5
Regeneron Healthcare Solutions, Inc. $4,123.50 3
Amgen Inc. $2,320.00 2
Roche Products Limited $1,100.00 1
Gilead Sciences, Inc. $73.33 1

Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LEONARD H CALABRESE

NPI 1467415265 · CMS profile ID 65714

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

CLEVELAND, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1467415265?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LEONARD H CALABRESE, NPI 1467415265, CMS profile ID 65714. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1467415265?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). LEONARD H CALABRESE, NPI 1467415265, CMS profile ID 65714. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1467415265?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
LEONARD H CALABRESE, NPI 1467415265, CMS profile ID 65714, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–147 of 147 matching records. This page contains 47 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1467415265?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

147 matching records · $210,188.31 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 147 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–147 of 147.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $1,160.0006/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783418653 CMS
UCB, Inc. $1,150.0006/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807353183 CMS
AstraZeneca Pharmaceuticals LP $124.9906/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829815619 CMS
Janssen Scientific Affairs, LLC $500.0005/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788274943 CMS
AstraZeneca Pharmaceuticals LP $1,050.0005/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830084001 CMS
GlaxoSmithKline, LLC. $1,200.0005/25/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802690679 CMS
E.R. Squibb & Sons, L.L.C. $1,160.0005/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783418639 CMS
AstraZeneca Pharmaceuticals LP $1,050.0005/10/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829482849 CMS
Janssen Biotech, Inc. $1,150.0005/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788274927 CMS
Janssen Biotech, Inc. $1,150.0005/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788274929 CMS
Janssen Scientific Affairs, LLC $3,162.5005/06/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788274941 CMS
UCB, Inc. $1,150.0005/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807339689 CMS
UCB, Inc. $1,150.0005/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807341807 CMS
AbbVie Inc. $1,500.0004/28/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794202107 CMS
GlaxoSmithKline, LLC. $3,300.0004/23/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802145851 CMS
AbbVie Inc. $1,500.0004/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794202105 CMS
GENZYME CORPORATION $2,196.0004/21/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413301 CMS
GENZYME CORPORATION $2,196.0004/21/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413305 CMS
GlaxoSmithKline, LLC. $2,200.0004/21/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803174809 CMS
GlaxoSmithKline, LLC. $300.0004/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802128959 CMS
GENZYME CORPORATION $2,196.0004/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413309 CMS
AbbVie Inc. $93.8404/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794202103 CMS
GlaxoSmithKline, LLC. $9,350.0004/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802452850 CMS
GlaxoSmithKline, LLC. $1,200.0004/06/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802834145 CMS
GENZYME CORPORATION $12,040.0004/05/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413243 CMS
E.R. Squibb & Sons, L.L.C. $1,160.0003/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783418631 CMS
Novartis Pharmaceuticals Corporation $1,515.0003/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812624827 CMS
AstraZeneca Pharmaceuticals LP $1,074.0003/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830259929 CMS
Roche Products Limited $1,100.0003/11/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835940833 CMS
Janssen Biotech, Inc. $1,437.5003/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788274923 CMS
GENZYME CORPORATION $2,107.0003/06/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413247 CMS
E.R. Squibb & Sons, L.L.C. $1,160.0003/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783418625 CMS
AbbVie Inc. $1,500.0003/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794202101 CMS
GENZYME CORPORATION $3,610.0002/23/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413353 CMS
GENZYME CORPORATION $2,107.0002/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413233 CMS
GENZYME CORPORATION $6,498.0002/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413393 CMS
GENZYME CORPORATION $2,107.0002/10/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413238 CMS
GlaxoSmithKline, LLC. $2,750.0002/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801839171 CMS
Novartis Pharmaceuticals Corporation $1,010.0002/06/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812624825 CMS
AbbVie Inc. $1,000.0002/05/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794202099 CMS
AstraZeneca Pharmaceuticals LP $2,148.0002/03/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829306947 CMS
E.R. Squibb & Sons, L.L.C. $600.0002/02/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783418753 CMS
GENZYME CORPORATION $2,107.0001/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843413205 CMS
Amgen Inc. $580.0001/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826381291 CMS
Amgen Inc. $1,740.0001/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826381293 CMS
AstraZeneca Pharmaceuticals LP $2,685.0001/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829512553 CMS
Gilead Sciences, Inc. $73.3301/04/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845881577 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $335,502.75 286
PY2020 $244,707.50 150
PY2021 $210,188.31 147
PY2022 $316,455.15 245
PY2023 $250,872.06 185
PY2024 $259,438.50 184
PY2025 $294,074.30 214

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $2,200.00 1
PY2024 Recipient $3,300.00 1
PY2021 Recipient $3,000.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1 record in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Amgen Inc. $2,200.00 10/15/2025 Covered Recipient Physician A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HZN-1116 in Participants With Sjgrens Syndrome No dispute reported 06/30/2026 1246637002